{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T18:15:50Z","timestamp":1758046550794,"version":"3.44.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,12]],"date-time":"2021-06-12T00:00:00Z","timestamp":1623456000000},"content-version":"am","delay-in-days":346,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales Pharmaceutiques Fran\u00e7aises"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.pharma.2020.02.005","type":"journal-article","created":{"date-parts":[[2020,4,3]],"date-time":"2020-04-03T01:56:10Z","timestamp":1585878970000},"page":"287-293","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Exemple d\u2019un cas d\u2019hyperkali\u00e9mie du nourrisson\u00a0: proposition d\u2019un circuit pour le pr\u00e9traitement du lait infantile par r\u00e9sine de polystyr\u00e8ne sulfonate de sodium \u00e0 l\u2019h\u00f4pital"],"prefix":"10.1016","volume":"78","author":[{"given":"S.","family":"Robert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.-E.","family":"Nisse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Henn-M\u00e9n\u00e9tr\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Vrillon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Demor\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharma.2020.02.005_bib0130","first-page":"253","article-title":"UK Renal Registry\u00a0\u2013\u00a020th Annual Report of the Renal Association","volume":"139","author":"Byrne","year":"2018","journal-title":"Nephron"},{"key":"10.1016\/j.pharma.2020.02.005_bib0135","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1111\/j.1471-0528.2012.03476.x","article-title":"Congenital lower urinary tract obstruction: a population-based epidemiological study","volume":"119","author":"Malin","year":"2012","journal-title":"BJOG Int J Obstet Gynaecol"},{"key":"10.1016\/j.pharma.2020.02.005_bib0140","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1016\/S0022-5347(01)66186-X","article-title":"The long-term outcome of posterior urethral valves treated with primary valve ablation and observation","volume":"155","author":"Smith","year":"1996","journal-title":"J Urol"},{"key":"10.1016\/j.pharma.2020.02.005_bib0145","series-title":"Norme pour les pr\u00e9parations destin\u00e9es aux nourrissons et les pr\u00e9parations donn\u00e9es \u00e0 des fins m\u00e9dicales sp\u00e9ciales aux nourrissons","first-page":"19","author":"Maskeliunas","year":"1981"},{"key":"10.1016\/j.pharma.2020.02.005_bib0150","unstructured":"R\u00e9sum\u00e9 des Caract\u00e9ristiques du Produit 2019. http:\/\/agence-prd.ansm.sante.fr\/php\/ecodex\/rcp\/R0216371.htm (consult\u00e9 le 19\/02\/2020)."},{"key":"10.1016\/j.pharma.2020.02.005_bib0155","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/BF02467356","article-title":"Complications following oral administration of exchange resins in extremely low-birth-weight infants","volume":"146","author":"Ohlsson","year":"1987","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.pharma.2020.02.005_bib0160","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJM196101192640302","article-title":"Treatment of the oliguric patient with a new sodium-exchange resin and sorbitol","volume":"264","author":"Flinn","year":"1961","journal-title":"N Engl J Med"},{"year":"2017","series-title":"Pediatric & Neonatal Dosage Handbook","author":"Taketomo","key":"10.1016\/j.pharma.2020.02.005_bib0165"},{"key":"10.1016\/j.pharma.2020.02.005_bib0170","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/BF00852836","article-title":"Pretreatment of formula with sodium polystyrene sulfonate to reduce dietary potassium intake","volume":"5","author":"Bunchman","year":"1991","journal-title":"Pediatr Nephrol Berl Ger"},{"key":"10.1016\/j.pharma.2020.02.005_bib0175","first-page":"274","article-title":"Mineral content of infant formula after treatment with sodium polystyrene sulfonate or calcium polystyrene sulfonate","volume":"14","author":"Fassinger","year":"1998","journal-title":"Adv Perit Dial Conf Perit Dial"},{"key":"10.1016\/j.pharma.2020.02.005_bib0180","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s40272-012-0003-3","article-title":"Pretreatment of infant formula with sodium polystyrene sulfonate: focus on optimal amount and contact time","volume":"15","author":"Cameron J-CF","year":"2013","journal-title":"Paediatr Drugs"},{"key":"10.1016\/j.pharma.2020.02.005_bib0185","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1177\/014860710402800276","article-title":"Sodium polystyrene sulfonate used to reduce the potassium content of a high-protein enteral formula: a quantitative analysis","volume":"28","author":"Rivard","year":"2004","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"10.1016\/j.pharma.2020.02.005_bib0190","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1053\/j.jrn.2013.02.011","article-title":"Pretreatment of formula or expressed breast milk with sodium polystyrene sulfonate (Kayexalate(\u00ae)) as a treatment for hyperkalemia in infants with acute or chronic renal insufficiency","volume":"23","author":"Thompson","year":"2013","journal-title":"J Ren Nutr"},{"key":"10.1016\/j.pharma.2020.02.005_bib0195","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/ckj\/sfx138","article-title":"Pretreatment of enteral nutrition with sodium polystyrene sulfonate: effective, but beware the high prevalence of electrolyte derangements in clinical practice","volume":"11","author":"Le Palma","year":"2018","journal-title":"Clin Kidney J"},{"volume":"vol. L5111-1","year":"2007","key":"10.1016\/j.pharma.2020.02.005_bib0200"},{"volume":"vol. L5126-1","year":"2017","key":"10.1016\/j.pharma.2020.02.005_bib0205"},{"year":"2011","series-title":"Arr\u00eat\u00e9 du 6\u00a0avril 2011\u00a0relatif au management de la qualit\u00e9 de la prise en charge m\u00e9dicamenteuse et aux m\u00e9dicaments dans les \u00e9tablissements de sant\u00e9","key":"10.1016\/j.pharma.2020.02.005_bib0210"},{"key":"10.1016\/j.pharma.2020.02.005_bib0215","unstructured":"R\u00e8glement (UE) no 609\/2013\u00a0du Parlement europ\u00e9en et du Conseil du 12\u00a0juin 2013\u00a0concernant les denr\u00e9es alimentaires destin\u00e9es aux nourrissons et aux enfants en bas \u00e2ge, les denr\u00e9es alimentaires destin\u00e9es \u00e0 des fins m\u00e9dicales sp\u00e9ciales et les substituts de la ration journali\u00e8re totale pour contr\u00f4le du poids et abrogeant la directive 92\/52\/CEE du Conseil, les directives 96\/8\/CE, 1999\/21\/CE, 2006\/125\/CE et 2006\/141\/CE de la Commission, la directive 2009\/39\/CE du Parlement europ\u00e9en et du Conseil et les r\u00e8glements (CE) no 41\/2009\u00a0et (CE) no 953\/2009\u00a0de la CommissionTexte pr\u00e9sentant de l\u2019int\u00e9r\u00eat pour l\u2019EEE 2013."},{"year":"2000","series-title":"Arr\u00eat\u00e9 du 20\u00a0septembre 2000\u00a0relatif aux aliments di\u00e9t\u00e9tiques destin\u00e9s \u00e0 des fins m\u00e9dicales sp\u00e9ciales","key":"10.1016\/j.pharma.2020.02.005_bib0220"},{"key":"10.1016\/j.pharma.2020.02.005_bib0225","first-page":"210","article-title":"Aliments di\u00e9t\u00e9tiques destin\u00e9s \u00e0 des fins m\u00e9dicales sp\u00e9ciales\u00a0: bases r\u00e9glementaires et enjeux pour les pharmacies \u00e0 usage int\u00e9rieur","volume":"50","author":"Pigneret","year":"2015","journal-title":"Pharm Hosp Clin"},{"key":"10.1016\/j.pharma.2020.02.005_bib0230","unstructured":"Bultel C, Turck D, Thomann C.\u00a0Recommandations d\u2019hygi\u00e8ne pour la pr\u00e9paration et la conservation des biberons 2018."},{"key":"10.1016\/j.pharma.2020.02.005_bib0235","unstructured":"Agence nationale de s\u00e9curit\u00e9 du m\u00e9dicament et des produits de sant\u00e9. Bonnes pratiques de pr\u00e9paration 2007."},{"year":"1996","series-title":"Circulaire DGS\/PS3\/DH\/FH1\u00a0no\u00a096-31\u00a0du 19\u00a0janvier 1996","key":"10.1016\/j.pharma.2020.02.005_bib0240"},{"volume":"vol. R4311-1","year":"2004","key":"10.1016\/j.pharma.2020.02.005_bib0245"},{"key":"10.1016\/j.pharma.2020.02.005_bib0125","unstructured":"Minist\u00e8re des Affaires sociales et de la Sant\u00e9. Gestion des d\u00e9chets produits par les \u00e9tablissements de sant\u00e9 2016."}],"container-title":["Annales Pharmaceutiques Fran\u00e7aises"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003450920300328?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003450920300328?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T23:34:06Z","timestamp":1757720046000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003450920300328"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S0003450920300328"],"URL":"https:\/\/doi.org\/10.1016\/j.pharma.2020.02.005","relation":{},"ISSN":["0003-4509"],"issn-type":[{"type":"print","value":"0003-4509"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exemple d\u2019un cas d\u2019hyperkali\u00e9mie du nourrisson\u00a0: proposition d\u2019un circuit pour le pr\u00e9traitement du lait infantile par r\u00e9sine de polystyr\u00e8ne sulfonate de sodium \u00e0 l\u2019h\u00f4pital","name":"articletitle","label":"Article Title"},{"value":"Annales Pharmaceutiques Fran\u00e7aises","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharma.2020.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Acad\u00e9mie Nationale de Pharmacie. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}